- QuantiFERON cytomegalovirus assay for evaluation of CMV reactivity among renal transplant recipient and donor in Bangladesh
-
Nobi F, Bari A, Salma Begum NA, Kashem TS, Uz-Zaman Arefin MS, Nomany S, Rahman M, Akhter N, Yousuf E, Rashid HU
- KMID: 2535467
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S250.
- doi: 10.4285/ATW2022.F-3896
Background: CMV is the one of the most common viral infections after kidney transplantation with significant morbidity and mortality. Currently sero-positivity for CMV IgG before solid organ transplantation is the... -
- CITED
-
- Close
- SHARE
-
- Close
- Varicella zoster virus and cytomegalovirus co-infection in a live related kidney transplant recipient: a case report
-
Bari A, Salma Begum NA, Nobi F, Rashid M, Uz-Zaman Arefin MS, Nomany S, Rashid HU, Sayed A, Islam S
- KMID: 2535461
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S244.
- doi: 10.4285/ATW2022.F-3847
Infections are common complications in kidney transplant recipients owing to the lifelong immunosuppression. Cytomegalovirus (CMV) and varicella zoster virus (VZV) infections are quite common in the posttransplant period. Coinfection with... -
- CITED
-
- Close
- SHARE
-
- Close
- Deceased organ transplantation: knowledge, awareness, and attitude among health care professionals in Bangladesh
-
Rashid M, Bari A, Nobi F, Salma Begum NA, Zaman Arefin MSU, Nomani S, Sayed A, Rashid HU, Ahn C
- KMID: 2535474
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S257.
- doi: 10.4285/ATW2022.F-4026
Background: Asia has greatest growth rate for number of chronic diseases and end-stage organ failure, but has the lowest rate of organ transplant, particularly deceased donor. This survey was conducted... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study
-
Marcheselli R, Marcheselli L, Cortesi L, Bari A, Cirilli C, Pozzi S, Ferri P, Napolitano M, Federico M, Sacchi S
- KMID: 2176287
- J Breast Cancer.
- 2015 Dec;18(4):378-385.
- doi: 10.4048/jbc.2015.18.4.378
PURPOSE: Evolving therapies have improved the prognoses of patients with breast cancer; and currently, the number of long-term survivors is continuously increasing. However, these patients are at increased risk of... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients
-
Akbarin MM, Shirdel A, Bari A, Mohaddes S, Rafatpanah H, Karimani E, Etminani K, Golabpour , Torshizi R
- KMID: 2413327
- Blood Res.
- 2017 Jun;52(2):106-111.
- doi: 10.5045/br.2017.52.21.106
BACKGROUND: Adult T-cell leukemia/lymphoma (ATLL) is an aggressive malignancy with very poor prognosis and short survival, caused by the human T-lymphotropic virus type-1 (HTLV-1). The HTLV-1 biomarkers trans-activator x (TAX)... -
- CITED
-
- Close
- SHARE
-
- Close
